Ann: Annual Report and Notice of Annual General Meeting, page-118

I suppose that BIT haven’t evidence to support HIV ART treatment interruption.

Begs the question about 314, why think 314 if you believe 225 should be part of the first HIV cure?

One would think the virus is also hiding in places where 225 doesn’t work , or isn’t strong enough.

The immune response angle has been around a long time (DYOR), and they seem to be saying that they are looking to license and approve it as such.

Hence the apparent double talk about elimination and immune response. Keeping the dream alive on one hand but pointing to next gen on the other.